Business Context and Reporting Period
Company: Recursion Pharmaceuticals, Inc. (RXRX)
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2022
Reporting Period: First Quarter ended March 31, 2022
Context: The registrant is an emerging growth company incorporated in Delaware. This filing announces the release of Q1 2022 results of operations and financial condition via a press release (Exhibit 99.1) and an updated investor presentation (Exhibit 99.2).
Key Financial Metrics
The provided Form 8-K text serves as a notification of the release of financial results but does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that results for the first quarter of 2022 have been issued.
Guidance, Outlook, and Risks
- Management Commentary: An updated investor presentation was released on May 10, 2022, intended for use in investor meetings.
- Legal Disclaimer: The information furnished in this 8-K (including the press release and presentation) is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
- Risks/Contingencies: No specific risks or contingencies are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2022 revenue, net loss, and cash position figures.
- Examine Exhibit 99.2 (Investor Presentation) for updated operational milestones and forward-looking guidance.
- Verify the company's status as an Emerging Growth Company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol RXRX on the Nasdaq Global Select Market.